Obesity and the metabolic syndrome essay
Metabolic syndrome is a serious health condition that puts people at higher risk for heart disease, diabetes, stroke and diseases related to fatty deposits in the artery walls and atherosclerosis. Underlying causes of metabolic syndrome include overweight and obesity, insulin resistance, physical inactivity, genetic factors and increasing age.1. Introduction. Obesity is a chronic disease characterized by the abnormal or excessive accumulation of body fat. A body mass index BMI which is calculated by weight in kilograms divided by the square of height in meters kg is often used to define obesity. BMI It is considered underweight or normal weight, followed by Summary. Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and an increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome has increased. Metabolic syndrome refers to a group of conditions that increase an individual's risk of diabetes, stroke or developing heart disease. Patwardhan et al. 2017. Metabolic syndrome has specifically shown that it can lead to cases of dyslipidemia Wang et al. 2012. Obesity. Obesity is often considered to be the result of excessive calorie consumption, food intake and/or insufficient or inadequate calorie consumption, metabolic and physical activity. Obesity is a complex and chronic non-communicable disease that affects more than a third of the world's population Hruby and Hu, 2015 The metabolic syndrome is defined as a cluster of at least three of five clinical risk factors: abdominal visceral obesity, hypertension, elevated serum triglycerides , low serum high-density lipoprotein HDL and insulin resistance. It is estimated that this will affect the world's adult population. Abdominal visceral obesity is suspected. Metabolic syndrome MetS was developed by the National Cholesterol Education Program Adult Treatment Panel III, which identifies adults with cardiometabolic risk factors hyperglycemia, increased central adiposity, increased triglycerides, decreased high-density lipoprotein cholesterol, and increased blood, Metabolic syndrome MetS is a cluster of metabolic abnormalities, including hypertension, central obesity, insulin resistance and atherogenic dyslipidemia. MetS is strongly associated with an increased risk of developing atherosclerotic cardiovascular disease. pathogenesis of MetS involves both genetic and 1. Introduction. Obesity is increasing worldwide and is associated with the development of the metabolic syndrome MetS, a cluster of cardiometabolic risk factors and comorbidities that confer a high risk of cardiovascular disease and diabetes. MetS is characterized by an increase in white adipose tissue and insulin. considered one of the top public health concerns and ranked as the fifth leading cause of death worldwide. Overweight and obesity are one of the leading lifestyle diseases that lead to further health problems and contribute to numerous chronic diseases, including cancer, diabetes, metabolic syndrome and cardiovascular disease. Background. Metabolic syndrome is defined as a cluster of at least three of five clinical risk factors: abdominal visceral obesity, hypertension, elevated serum triglycerides, low serum high-density lipoprotein HDL, and insulin resistance. The prevalence of metabolic syndrome is estimated at,